SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-053914
Filing Date
2011-05-25
Accepted
2011-05-25 16:21:17
Documents
6
Period of Report
2011-05-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g27379e8vk.htm 8-K 18331
2 EX-10.1 g27379exv10w1.htm EX-10.1 48255
3 EX-99.1 g27379exv99w1.htm EX-99.1 6139
4 GRAPHIC g27379g2737901.gif GRAPHIC 3863
5 GRAPHIC g27379g2737902.gif GRAPHIC 73
6 GRAPHIC g27379g2737900.gif GRAPHIC 4436
  Complete submission text file 0000950123-11-053914.txt   85974
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 11871170
SIC: 2836 Biological Products, (No Diagnostic Substances)